These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 34604591)

  • 1. Establishment of brucellosis relapse and complications registry: a study protocol.
    Keramat F; Mamani M; Adabi M; Khazaei S; Shivapoor Z; Karami M
    J Prev Med Hyg; 2021 Jun; 62(2):E496-E500. PubMed ID: 34604591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and Risk Factors of Brucellosis in Kermanshah Province, Iran During 2010-2014.
    Rajabi J; Hamidi-Farahani R; Mansouri F; Soleiman-Meigooni S
    Infect Disord Drug Targets; 2020; 20(2):203-207. PubMed ID: 30539704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiological characteristics of human brucellosis in Hamadan Province during 2009-2015: results from the National Notifiable Diseases Surveillance System.
    Nematollahi S; Ayubi E; Karami M; Khazaei S; Shojaeian M; Zamani R; Mansori K; Gholamaliee B
    Int J Infect Dis; 2017 Aug; 61():56-61. PubMed ID: 28602765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroprevalence of Brucellosis among General Population in Famenin City, Western Iran in 2016: The Famenin Brucellosis Cohort Study.
    Keramat F; Karami M; Alikhani MY; Bashirian S; Moghimbeigi A; Hashemi SH; Mamani M; Shivapoor Z; Bosilkovski M; Adabi M
    Arch Iran Med; 2020 Nov; 23(11):749-756. PubMed ID: 33220691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiological features of brucellosis and factors affecting its treatment failure and relapse in Qom Province, Iran.
    Mohammadbeigi A; Saghafipour A; Hamta A; Khazaei S; Maghsoudi A; Shams S
    Ghana Med J; 2021 Sep; 55(3):206-212. PubMed ID: 35950176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Incidence and Geographical Distribution of Brucellosis in Iran Using Geographic Information System and Prediction of its Incidence in 2021.
    Shirzadi MR; Mohammadi P; Moradi G; Goodarzi E; Khazaei S; Moayed L; Khazaei Z
    J Prev Med Hyg; 2021 Sep; 62(3):E635-E634. PubMed ID: 34909491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brucellosis: The Current Situation in Iran and Neighboring Countries.
    Sohrabi A; Hajia M
    Infect Disord Drug Targets; 2020; 20(5):763-764. PubMed ID: 31549597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroprevalence of Brucellosis in Butchers, Veterinarians and Slaughterhouse Workers in Hamadan, Western Iran.
    Mamani M; Majzoobi MM; Keramat F; Varmaghani N; Moghimbeigi A
    J Res Health Sci; 2018 Feb; 18(1):e00406. PubMed ID: 29777092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk Factors for Relapse of Human Brucellosis.
    Hasanjani Roushan MR; Moulana Z; Mohseni Afshar Z; Ebrahimpour S
    Glob J Health Sci; 2015 Nov; 8(7):77-82. PubMed ID: 26925907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiologic, clinical and laboratory findings of patients with brucellosis in Hamadan, west of Iran.
    Eini P; Keramat F; Hasanzadehhoseinabadi M
    J Res Health Sci; 2012 Dec; 12(2):105-8. PubMed ID: 23241521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiological features of human brucellosis in central Iran, 2006-2011.
    Zeinalian Dastjerdi M; Fadaei Nobari R; Ramazanpour J
    Public Health; 2012 Dec; 126(12):1058-62. PubMed ID: 22884862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spatial and spatio-temporal analysis of human brucellosis in Iran.
    Mollalo A; Alimohammadi A; Khoshabi M
    Trans R Soc Trop Med Hyg; 2014 Nov; 108(11):721-8. PubMed ID: 25157126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteoarticular complications of brucellosis in Hamedan, an endemic area in the west of Iran.
    Hashemi SH; Keramat F; Ranjbar M; Mamani M; Farzam A; Jamal-Omidi S
    Int J Infect Dis; 2007 Nov; 11(6):496-500. PubMed ID: 17344084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiological and clinical features of Brucella arthritis in 24 children.
    Zamani A; Kooraki S; Mohazab RA; Zamani N; Matloob R; Hayatbakhsh MR; Raeeskarami SR
    Ann Saudi Med; 2011; 31(3):270-3. PubMed ID: 21623056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Forecasting the monthly incidence rate of brucellosis in west of Iran using time series and data mining from 2010 to 2019.
    Bagheri H; Tapak L; Karami M; Hosseinkhani Z; Najari H; Karimi S; Cheraghi Z
    PLoS One; 2020; 15(5):e0232910. PubMed ID: 32396582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiological Features of Human Brucellosis in Iran (2011-2018) and Prediction of Brucellosis with Data-Mining Models.
    Bagheri H; Tapak L; Karami M; Amiri B; Cheraghi Z
    J Res Health Sci; 2019 Dec; 19(4):e00462. PubMed ID: 32291361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiological, laboratory, diagnostic and public health aspects of human brucellosis in western Iran.
    Kassiri H; Amani H; Lotfi M
    Asian Pac J Trop Biomed; 2013 Aug; 3(8):589-94; discussion 593-4. PubMed ID: 23905014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spatiotemporal analysis of brucellosis incidence in Iran from 2011 to 2014 using GIS.
    Pakzad R; Pakzad I; Safiri S; Shirzadi MR; Mohammadpour M; Behroozi A; Sullman MJM; Janati A
    Int J Infect Dis; 2018 Feb; 67():129-136. PubMed ID: 29122689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changing Patterns in Epidemiology of Brucellosis in the South of Iran (2015-2020): Based on Cochrane-Armitage Trend Test.
    Delam H; Keshtkaran Z; Rezaei B; Soufi O; Bazrafshan MR
    Ann Glob Health; 2022; 88(1):11. PubMed ID: 35223430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of brucellosis in Iran: A comprehensive systematic review and meta-analysis study.
    Mirnejad R; Jazi FM; Mostafaei S; Sedighi M
    Microb Pathog; 2017 Aug; 109():239-247. PubMed ID: 28602839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.